Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001702031-26-000002

SVP, Business Development sold 42,431 shares at $8.27 ($350,730)

From the SEC's structured data for this filing

Trades in this filing

Birznieks Gunther · SVP, Business Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Sale : show line 1 in the form −42,431 $8.27 $350,730 494,197 D
Open-market sales · 42,431 sh · avg $8.27 · $350,730
Loading xslF345X05/ownership.xml…